{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:43:45Z","timestamp":1788435825717,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunologic and inflammatory adverse effects following vaccination against COVID-19 are being reported. While some reactions may develop denovo others concern its immunogenic effect in patients with pre-existing inflammatory conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective consecutive patients diagnosed with ocular inflammatory manifestations within 8 weeks of receiving COVID-19 vaccination who presented to a tertiary eye care centre in South India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ninety-eight eyes of 67 patients presenting with ocular inflammatory manifestations within 8 weeks following COVID-19 vaccination were studied. The mean age was 43 years (+\/- 14.82; range 19\u201380 years). The most common presentations were anterior uveitis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931, 31.7%), followed by panuveitis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924, 24.5%). The mean time to onset of symptoms was 25 days (+\/- 15.48; range 2\u201355 days) following a dose of vaccine.\n                    <\/jats:p>\n                    <jats:p>\n                      Among all patients, 39 (58.2%) had a previous history of ocular inflammation. Mean presenting visual acuity was 0.4 (0-4) logMAR units and mean final visual acuity was 0.2 (0-4) logMAR units. The causes for reduced vision included of cystoid macular edema (\n                      <jats:italic>n<\/jats:italic>\n                      =2, 2%), chorioretinal atrophy (\n                      <jats:italic>n<\/jats:italic>\n                      =2.2%), optic atrophy (\n                      <jats:italic>n<\/jats:italic>\n                      =1.1%), retinal vascular occlusion (\n                      <jats:italic>n<\/jats:italic>\n                      =1.1%) and acute retinal necrosis (\n                      <jats:italic>n<\/jats:italic>\n                      =1.1%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Infective and immunogenic adverse events should be watched out for after COVID-19 vaccination. It is difficult to establish causality for such manifestations, nevertheless, most of them were mild and had good final visual outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-023-00358-x","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T21:02:18Z","timestamp":1695416538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ocular manifestations following COVID-19 vaccination"],"prefix":"10.1186","volume":"13","author":[{"given":"Padmamalini","family":"Mahendradas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Bhakti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Sangoram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush","family":"Kawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"key":"358_CR1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at https:\/\/covid19.who.int\/ [Accessed 26 Feb 2022]"},{"issue":"4","key":"358_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12291-021-00968-z","volume":"36","author":"RJ Kaur","year":"2021","unstructured":"Kaur RJ, Dutta S, Bhardwaj P, Charan J, Dhingra S, Mitra P, Singh K, Yadav D, Sharma P, Misra S (2021) Adverse events reported from COVID-19 vaccine trials: a systematic review. Indian J Clin biochemistry: IJCB 36(4):427\u2013439","journal-title":"Indian J Clin biochemistry: IJCB"},{"issue":"10","key":"358_CR3","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","volume":"6","author":"J Montgomery","year":"2021","unstructured":"Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, Loran D, Hrncir D, Herring K, Platzer M, Adams N, Sanou A, Cooper LT, Jr (2021) Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol 6(10):1202\u20131206","journal-title":"JAMA Cardiol"},{"issue":"21","key":"358_CR4","first-page":"01156","volume":"S1443\u20139506","author":"S Pepe","year":"2021","unstructured":"Pepe S, Gregory AT, Denniss AR (2021) Myocarditis, Pericarditis and Cardiomyopathy after COVID-19 vaccination. Heart Lung Circ S1443\u20139506(21):01156\u201301152","journal-title":"Heart Lung Circ"},{"issue":"45","key":"358_CR5","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.3346\/jkms.2021.36.e312","volume":"36","author":"JW Park","year":"2021","unstructured":"Park JW, Yu SN, Chang SH, Ahn YH, Jeon MH (2021) Multisystem inflammatory syndrome in an adult after COVID-19 vaccination: a Case Report and Literature Review. J Korean Med Sci 36(45) e312","journal-title":"J Korean Med Sci"},{"issue":"5","key":"358_CR6","doi-asserted-by":"publisher","first-page":"102524","DOI":"10.1016\/j.autrev.2020.102524","volume":"19","author":"F Caso","year":"2020","unstructured":"Caso F, Costa L, Ruscitti P, Navarini L, Del Puente A, Giacomelli R, Scarpa R (2020) Could Sars-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun rev 19(5):102524","journal-title":"Autoimmun rev"},{"issue":"8","key":"358_CR7","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","volume":"19","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V, Semenova N, Amital H, Shoenfeld Y (2020) Covid-19 and autoimmunity. Autoimmun rev 19(8):102597","journal-title":"Autoimmun rev"},{"issue":"1","key":"358_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3109\/15569520903427717","volume":"29","author":"FW Fraunfelder","year":"2010","unstructured":"Fraunfelder FW, Suhler EB, Fraunfelder FT (2010) Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol 29(1):26\u201329","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"358_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/15748863113086660062","volume":"9","author":"HD Holt","year":"2014","unstructured":"Holt HD, Hinkle DM, Falk NS, Fraunfelder FT, Fraunfelder FW (2014) Human papilloma virus vaccine associated uveitis. Curr Drug Saf 9(1):65\u201368","journal-title":"Curr Drug Saf"},{"issue":"4","key":"358_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/09273948.2018.1483520","volume":"27","author":"AB Sood","year":"2019","unstructured":"Sood AB, O\u2019Keefe G, Bui D, Jain N (2019) Vogt-Koyanagi-Harada disease associated with hepatitis B vaccination. Ocul Immunol Inflamm 27(4):524\u2013527","journal-title":"Ocul Immunol Inflamm"},{"key":"358_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/OPTH.S37443","volume":"7","author":"S Escott","year":"2013","unstructured":"Escott S, Tarabishy AB, Davidorf FH (2013) Multifocal choroiditis following simultaneous hepatitis a, typhoid, and yellow fever vaccination. Clin Ophthalmol 7:363\u2013365. https:\/\/doi.org\/10.2147\/OPTH.S37443","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"358_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/09273948.2017.1423334","volume":"27","author":"A Abou-Samra","year":"2019","unstructured":"Abou-Samra A, Tarabishy AB (2019) Multiple evanescent white dot syndrome following intradermal influenza vaccination. Ocul Immunol Inflamm 27(4):528\u2013530","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"358_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/09273948.2018.1510529","volume":"27","author":"AL Biancardi","year":"2019","unstructured":"Biancardi AL, Moraes HV Jr (2019) Anterior and intermediate uveitis following yellow fever vaccination with fractional dose: case reports. Ocul Immunol Inflamm 27(4):521\u2013523. https:\/\/doi.org\/10.1080\/09273948.2018.1510529","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"358_CR14","first-page":"48","volume":"113","author":"M Benage","year":"2016","unstructured":"Benage M, Fraunfelder FW (2016) Vaccine-associated uveitis. Mo Med 113(1):48\u201352","journal-title":"Mo Med"},{"issue":"4","key":"358_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/09273948.2019.162618816","volume":"27","author":"ET Cunningham Jr","year":"2019","unstructured":"Cunningham ET Jr, Moorthy RS, Fraunfelder FW, Zierhut M (2019) Vaccine- associated uveitis. Ocul Immunol Inflamm 27(4):517\u2013520. https:\/\/doi.org\/10.1 080\/09273948.2019.162618816","journal-title":"Ocul Immunol Inflamm"},{"key":"358_CR16","doi-asserted-by":"publisher","unstructured":"Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Adjuvants and autoimmunity. Lupus. 18:1217\u20131225. https:\/\/doi.org\/10.1177\/0961203309345724","DOI":"10.1177\/0961203309345724"},{"key":"358_CR17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","volume":"33","author":"RL Coffman","year":"2010","unstructured":"Coffman RL, Sher A, Seder RA (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33:492\u2013503. https:\/\/doi.org\/10.1016\/j.immuni.2010.10.002","journal-title":"Immunity"},{"key":"358_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.31138\/mjr.28.2.64","volume":"28","author":"A Watad","year":"2017","unstructured":"Watad A, Sharif K, Shoenfeld Y (2017) The ASIA syndrome: basic concepts. Mediterr J Rheumatol 28:64\u201369. https:\/\/doi.org\/10.31138\/mjr.28.2.64","journal-title":"Mediterr J Rheumatol"},{"key":"358_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/1044-579X(95)90007-1","volume":"6","author":"MJ McElrath","year":"1995","unstructured":"McElrath MJ (1995) Selection of potent immunological adjuvants for vaccine construction. Semin Cancer Biol 6:375\u2013385. https:\/\/doi.org\/10.1016\/1044-579X(95)90007-1","journal-title":"Semin Cancer Biol"},{"key":"358_CR20","doi-asserted-by":"publisher","unstructured":"Watad A, Quaresma M, Brown S, Cohen Tervaert JW, Rodr\u00edguez- Pint I, Cervera R et al (2017) Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld\u2019s syndrome)\u2014an update. Lupus. 26:675\u2013 81. doi: https:\/\/doi.org\/10.1177\/0961203316686406","DOI":"10.1177\/0961203316686406"},{"issue":"1","key":"358_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12348-021-00275-x","volume":"12","author":"I Testi","year":"2022","unstructured":"Testi I, Brand\u00e3o-de-Resende C, Agrawal R, Pavesio C, COVID-19 Vaccination Ocular Inflammatory Events Study Group (2022) Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J ophthalmic Inflamm Infect 12(1):4. https:\/\/doi.org\/10.1186\/s12348-021-00275-x","journal-title":"J ophthalmic Inflamm Infect"},{"key":"358_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003277","author":"T Rabinovitch","year":"2021","unstructured":"Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, Shaer B, Vishnevskia- Dai V, Shulman S, Newman H, Biadsy M, Masarwa D, Fischer N, Yovel O, Ben Zaken SG, Habot-Wilner Z (2021) Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association. Retina 2. https:\/\/doi.org\/10.1097\/IAE.0000000000003277","journal-title":"Retina 2"},{"issue":"10","key":"358_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1001\/jamaophthalmol.2021.3477","volume":"2","author":"F Pichi","year":"2021","unstructured":"Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG (2021) Association of Ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA Ophthalmol 2(10):1131. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.3477","journal-title":"JAMA Ophthalmol"},{"issue":"24","key":"358_CR24","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.3390\/jcm10245960","volume":"10","author":"E Bolletta","year":"2021","unstructured":"Bolletta E, Iannetta D, Mastrofilippo V, De Simone L, Gozzi F, Croci S, Bonacini M, Belloni L, Zerbini A, Adani C, Fontana L, Salvarani C, Cimino L (2021) Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med 10(24):5960. https:\/\/doi.org\/10.3390\/jcm10245960","journal-title":"J Clin Med"},{"key":"358_CR25","doi-asserted-by":"publisher","first-page":"823346","DOI":"10.3389\/fmed.2021.823346","volume":"8","author":"K Pang","year":"2022","unstructured":"Pang K, Pan L, Guo H, Wu X (2022) Case Report: Associated Ocular adverse reactions with inactivated COVID-19 vaccine in China. Front Med (Lausanne) 8:823346. https:\/\/doi.org\/10.3389\/fmed.2021.823346PMID: 35111790; PMCID: PMC8801805","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"358_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J, Hu C, Selvachandran S, Antonelli M, Murray B, Canas LS, Molteni E, Graham MS, Modat M, Joshi AD, Mangino M, Hammers A, Goodman AL, Chan AT, Wolf J, Steves CJ, Valdes AM, Ourselin S, Spector TD (2021) Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis 21(7):939\u2013949. https:\/\/doi.org\/10.1016\/S1473-3099(21)00224-3Epub 2021 Apr 27. PMID: 33930320; PMCID: PMC8078878","journal-title":"Lancet Infect Dis"},{"key":"358_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijid.2021.07.035","volume":"110","author":"G Renisi","year":"2021","unstructured":"Renisi G, Lombardi A, Stanzione M, Invernizzi A, Bandera A, Gori A (2021) Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? Int J Infect Dis 110:95\u201397. https:\/\/doi.org\/10.1016\/j.ijid.2021.07.035Epub 2021 Jul 18. PMID: 34289406","journal-title":"Int J Infect Dis"},{"key":"358_CR28","doi-asserted-by":"publisher","unstructured":"ElSheikh RH, Haseeb A, Eleiwa TK, Elhusseiny AM (2021) Acute uveitis following COVID-19 vaccination. Ocul Immunol Inflamm Aug11 1\u20133. https:\/\/doi.org\/10.1080\/09273948.2021.1962917","DOI":"10.1080\/09273948.2021.1962917"},{"key":"358_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.abj9256","volume":"6","author":"J Sprent","year":"2021","unstructured":"Sprent J, King C (2021) COVID-19 vaccine side effects: the positives about feeling bad. Sci Immunol 6:1\u20134 [CrossRef] [PubMed]","journal-title":"Sci Immunol"},{"key":"358_CR30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0140-6736(99)00623-6","volume":"353","author":"R Walter","year":"1999","unstructured":"Walter R, Hartmann K, Fleisch F, Reinhart WH, Kuhn M (1999) Reactivation of herpesvirus infections after vaccinations? Lancet 353:810. https:\/\/doi.org\/10.1016\/S0140-6736(99)00623-6","journal-title":"Lancet"},{"key":"358_CR31","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1002\/jmv.27036","volume":"93","author":"E Eid","year":"2021","unstructured":"Eid E, Abdullah L, Kurban M, Abbas O (2021) Herpes zoster emergence following mRNA COVID-19 vaccine. J Med Virol 93:5231\u20135232 [CrossRef]","journal-title":"J Med Virol"},{"key":"358_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12348-021-00260-4","volume":"11","author":"I Papasavvas","year":"2021","unstructured":"Papasavvas I, De Courten C, Herbort CP (2021) Jr. Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination\u2013report of three cases. J Ophthalmic Inflamm Infect 11:28 [CrossRef]","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"358_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/vaccines9091013","volume":"9","author":"KK Triantafyllidis","year":"2021","unstructured":"Triantafyllidis KK, Giannos P, Mian IT, Kyrtsonis G, Kechagias KS (2021) Varicella zoster virus reactivation following COVID-19 vaccination: a systematic review of case reports. Vaccines 9:1013","journal-title":"Vaccines"},{"issue":"1","key":"358_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12348-021-00262-2","volume":"11","author":"CP Herbort Jr","year":"2021","unstructured":"Herbort CP Jr, Papasavvas I (2021) Effect of SARS-CoV-2 mRNA vaccination on ocular herpes simplex and varicella-zoster virus reactivation: should preventive antiviral treatment be given in known herpes patients. J Ophthalmic Inflamm Infect 11(1):33. https:\/\/doi.org\/10.1186\/s12348-021-00262-2PMID: 34533628; PMCID: PMC8446741","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"358_CR35","doi-asserted-by":"publisher","unstructured":"Mishra SB, Mahendradas P, Kawali A, Sanjay S, Shetty R Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an asian indian male. Eur J Ophthalmol 2021 Sep 18:11206721211046485. doi: https:\/\/doi.org\/10.1177\/11206721211046485","DOI":"10.1177\/11206721211046485"},{"issue":"1","key":"358_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s40588-019-0114-5","volume":"6","author":"IA Khan","year":"2019","unstructured":"Khan IA, Ouellette C, Chen K, Moretto M, Toxoplasma (2019) Immunity and pathogenesis. Curr Clin Microbiol Rep 6(1):44\u201350. https:\/\/doi.org\/10.1007\/s40588-019-0114-5Epub 2019 Feb 4. PMID: 31179204; PMCID: PMC6547811","journal-title":"Curr Clin Microbiol Rep"},{"key":"358_CR37","doi-asserted-by":"publisher","unstructured":"Arora A, Handa S, Singh SR, Sharma A, Bansal R, Agrawal R, Gupta V (2022 Mar) Recurrence of tubercular choroiditis following anti-SARS-CoV-2 vaccination. Eur J Ophthalmol 21:11206721221088439. https:\/\/doi.org\/10.1177\/11206721221088439Epub ahead of print. PMID: 35306917; PMCID: PMC8938687","DOI":"10.1177\/11206721221088439"},{"issue":"10","key":"358_CR38","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","volume":"80","author":"V Furer","year":"2021","unstructured":"Furer V, Eviatar T, Zisman D, Peleg H, Paran D, Levartovsky D, Zisapel M, Elalouf O, Kaufman I, Meidan R, Broyde A, Polachek A, Wollman J, Litinsky I, Meridor K, Nochomovitz H, Silberman A, Rosenberg D, Feld J, Haddad A, Gazzit T, Elias M, Higazi N, Kharouf F, Shefer G, Sharon O, Pel S, Nevo S, Elkayam O (2021) Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis 80(10):1330\u20131338. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220647Epub 2021 Jun 14. PMID: 34127481; PMCID: PMC8206170","journal-title":"Ann Rheum Dis"},{"key":"358_CR39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/s40064-016-2223-4","volume":"5","author":"B Dogan","year":"2016","unstructured":"Dogan B, Erol MK, Cengiz A (2016) Vogt-Koyanagi-Harada disease following BCG vaccination and tuberculosis. Springerplus 5:603. https:\/\/doi.org\/10.1186\/s40064-016-2223-4","journal-title":"Springerplus"},{"issue":"2","key":"358_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/CJI.0000000000000154","volume":"40","author":"M Bricout","year":"2017","unstructured":"Bricout M, Petre A, Amini-Adle M, Bezza W, Seve P, Kodjikian L, Dalle S, Thomas L (2017) Vogt-Koyanagi-Harada-like syndrome complicating pembrolizumab treatment for metastatic melanoma. J Immunother 40(2):77\u201382","journal-title":"J Immunother"},{"issue":"1","key":"358_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/0301-4738.178141","volume":"64","author":"M Kim","year":"2016","unstructured":"Kim M (2016) Vogt-Koyanagi-Harada Syndrome following influenza vaccination. Indian J Ophthalmol 64(1):98. https:\/\/doi.org\/10.4103\/0301-4738.178141","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"358_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12348-021-00251-5","volume":"11","author":"I Papasavvas","year":"2021","unstructured":"Papasavvas I, Herbort CP Jr (2021) Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm Infect 11(1):21. https:\/\/doi.org\/10.1186\/s12348-021-00251-5PMID: 34224024; PMCID: PMC8256412","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"358_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40942-021-00319-3","volume":"7","author":"JJF Saraceno","year":"2021","unstructured":"Saraceno JJF, Souza GM, Dos Santos Finamor LP, Nascimento HM, Belfort R Jr (2021) Vogt-Koyanagi-Harada Syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. Int J Retina Vitreous 7(1):49. https:\/\/doi.org\/10.1186\/s40942-021-00319-3PMID: 34462013; PMCID: PMC8404022","journal-title":"Int J Retina Vitreous"},{"issue":"6","key":"358_CR44","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells11061012","volume":"11","author":"B De Domingo","year":"2022","unstructured":"De Domingo B, L\u00f3pez M, Lopez-Valladares M, Ortegon-Aguilar E, Sope\u00f1a-Perez-Arg\u00fcelles B, Gonzalez F (2022) Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 vaccine. Cells 11(6):1012. https:\/\/doi.org\/10.3390\/cells11061012PMID: 35326462; PMCID: PMC8947156","journal-title":"Cells"},{"key":"358_CR45","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","volume":"397","author":"A Bayas","year":"2021","unstructured":"Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M (2021) Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet 397:e11","journal-title":"Lancet"},{"key":"358_CR46","doi-asserted-by":"publisher","first-page":"e2021048","DOI":"10.4084\/MJHID.2021.048","volume":"13","author":"I Panovska-Stavridis","year":"2021","unstructured":"Panovska-Stavridis I, Pivkova-Veljanovska A, Trajkova S, Lazarevska M, Grozdanova A, Filipche (2021) V. A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-19. Mediterr J Hematol Infect Dis 13:e2021048","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"358_CR47","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1007\/s10792-021-01971-2","volume":"41","author":"AA Bialasiewicz","year":"2021","unstructured":"Bialasiewicz AA, Farah-Diab MS, Mebarki HT (2021) Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine. Int Ophthalmol 41:3889\u20133892","journal-title":"Int Ophthalmol"},{"key":"358_CR48","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.4103\/ijo.IJO_1477_21","volume":"69","author":"B Endo","year":"2021","unstructured":"Endo B, Bahamon S, Mart\u00ednez-Pulgar\u00edn D (2021) Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: a case report. Indian J Ophthalmol 69:2865\u20132866","journal-title":"Indian J Ophthalmol"},{"key":"358_CR49","doi-asserted-by":"publisher","unstructured":"Bohler AD, Strom ME, Sandvig KU, Moe MC, Jorstad OK (2021) Acute macular neuroretinopathy following COVID-19 vaccination. Eye 1\u20132. https:\/\/doi.org\/10.1038\/s41433-021-01610-1","DOI":"10.1038\/s41433-021-01610-1"},{"key":"358_CR50","doi-asserted-by":"publisher","unstructured":"Michel TSN, Gascon P, Dupessey F, Comet A, Attia R, David T et al (2021) Acute macular neuroretinopathy after COVID-19 vaccine. https:\/\/doi.org\/10.21203\/rs.3.rs-632137\/v1. J Ophthal Inflamm Infect","DOI":"10.21203\/rs.3.rs-632137\/v1"},{"key":"358_CR51","doi-asserted-by":"publisher","first-page":"e212471","DOI":"10.1001\/jamaophthalmol.2021.2471","volume":"139","author":"BAJ Book","year":"2021","unstructured":"Book BAJ, Schmidt B, Foerster AMH (2021) Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA Ophthalmol 139:e212471","journal-title":"JAMA Ophthalmol"},{"key":"358_CR52","doi-asserted-by":"publisher","unstructured":"Mambretti M, Huemer J, Torregrossa G, Ullrich M, Findl O, Casalino G (2021) Acute macular neuroretinopathy following coronavirus disease 2019 vaccination. Ocul Immunol Inflamm 1\u20134. https:\/\/doi.org\/10.1080\/09273948.2021.1946567","DOI":"10.1080\/09273948.2021.1946567"},{"key":"358_CR53","doi-asserted-by":"publisher","unstructured":"Sanjay S, Gadde SGK, Kumar Yadav N, Kawali A, Gupta A, Shetty R, Mahendradas P \u201cBilateral Sequential Acute Macular Neuroretinopathy in an Asian Indian Female with \u03b2 Thalassemia Trait following (Corona Virus Disease) COVID-19 Vaccination and Probable Recent COVID Infection- Multimodal Imaging Study.\u201c. Ocul Immunol Inflamm 2022 Jan 20:1\u20136. doi: https:\/\/doi.org\/10.1080\/09273948.2022.2026978","DOI":"10.1080\/09273948.2022.2026978"},{"key":"358_CR54","doi-asserted-by":"publisher","unstructured":"Singh RB, Singh Parmar UP, Kahale F, Agarwal A, Tsui E (2022) Vaccine-associated uveitis following SARS-CoV-2 vaccination: A CDC-VAERS database analysis. Ophthalmology. Aug 30:S0161-6420(22)00672-8. doi: https:\/\/doi.org\/10.1016\/j.ophtha.2022.08.027. Epub ahead of print. PMID: 36055601; PMCID: PMC9428109","DOI":"10.1016\/j.ophtha.2022.08.027"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-023-00358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-023-00358-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-023-00358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T01:04:47Z","timestamp":1700355887000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-023-00358-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1186\/s12348-023-00358-x","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,23]]},"assertion":[{"value":"3 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the hospital ethics committee (Narayana Nethralaya Ethics committee). All tenets of the Helsinki declaration were adhered to.Patient's written and informed consent was obtained for inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient\u2019s written and informed consent was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}